Search
Menu
Home
HTB
2014
May
HTB
May 2014
Contents
Editorial
May/June 2014: Volume 15 Number 5/6
Conference reports
49th Annual Meeting of the European Association for the Study of the Liver (EASL 2014), 9-13 April 2014, London
Activists protest the price of sofosbuvir: “So-Valdi, So-Expensive” – UK access already rationed
EASL 2014: summary of interferon-free HCV studies with new DAAs
WHO launch treatment guidelines for hepatitis C (2014)
3rd Joint Conference of BHIVA/BASHH, 1-4 April 2014, Liverpool
50% of UK seroconverters start ART within 1.4 years of infection: treating during primary infection should be a patient choice
PIVOT study: further analysis from five-year PI/r monotherapy strategy study
Sexually transmitted HCV in HIV positive and negative gay men
Annual HCV testing and use of core antigen to reduce costs and increase diagnosis during acute HCV
HIV positive attitudes to involvement as donors and recipients in organ transplant programmes
21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston
Pharmacokinetics of antiretrovirals in pregnancy
Better virologic outcomes with efavirenz vs lopinavir/ritonavir in pregnant women and no difference in risk of preterm birth
Once daily lopinavir/ritonavir not recommended for routine use in children and adolescents
Early antiretroviral treatment in infants
Hospitalisation among elite controllers
Catching up with pathogenesis and cure research from CROI 2014
Guidelines
US adult treatment guidelines updated (May 2014)
US PrEP guidelines (May 2014): emphasis on broad access may miss optimal use by people at highest risk
Side effects
No increase death rate in HIV positive people with renal dysfunction receiving tenofovir in Zambia
Hepatitis coinfection
EMA fast-track sofosbuvir/ledipasvir FDC for hepatitis C
Cure-related research
Reassessing the role of HDAC inhibitors in cure research
More on the links between the CD4/CD8 ratio, immunological perturbations, and risk of illness and death
Basic science and immunology
Incidence of HIV dual infections in US men who have sex with men
Other news
Partner 2 study extended for gay couples
TAILoR Study: telmisartan to reduce risk of insulin resistance: potential role for lipodystrophy
SCART study: selumetinib as potential treatment for HIV-related KS
Scotland agrees to free HIV treatment, regardless of residency status
On the web
Community reports and briefings
PDFs
Volume 15 Number 5/6 May/June 2014 PDF
HTB RSS
Early access
Future PrEP and updated lenacapavir studies with case details from PURPOSE 2
21 November 2024
Glasgow HIV Congress 2024
10 November 2024
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
Bipolar disorder in people living with HIV
1 November 2024
All early access reports
Current issues
November 2024
October 2024
September 2024
Back issues
Special report
HTB news: i-Base changes during 2024
1 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate